These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1428295)

  • 1. Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Barth J; Damoiseaux M; Möllmann H; Brandis KH; Hochhaus G; Derendorf H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):317-24. PubMed ID: 1428295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and pharmacodynamics of prednisolone following extremely high dosage as prednisolone hemisuccinate].
    Rohdewald VP; Rehder J; Möllmann H; Barth J; Derendorf H
    Arzneimittelforschung; 1987 Feb; 37(2):194-8. PubMed ID: 3580023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats.
    Li C; Kim M; Choi JS
    Arch Pharm Res; 2010 Sep; 33(9):1395-400. PubMed ID: 20945138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses.
    Whittem T; Pasloske KS; Heit MC; Ranasinghe MG
    J Vet Pharmacol Ther; 2008 Dec; 31(6):571-9. PubMed ID: 19000281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of cloprednol.
    Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H; Krieg M; Weisser H; Möllmann AC
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):1-5. PubMed ID: 8688990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and anti-inflammatory pharmacodynamics of prednisolone in cynomolgus monkey.
    Zheng YJ; Hawk M; Yuan H; Hope HR; Baratta M; Zutshi A
    Xenobiotica; 2009 Nov; 39(11):862-70. PubMed ID: 19845437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
    Kroschinsky FP; Friedrichsen K; Mueller J; Pursche S; Haenel M; Prondzinsky R; Ehninger G; Schleyer E
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):785-90. PubMed ID: 17579865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-dependent effects of prednisolone on lymphocyte subsets and mixed lymphocyte culture in humans.
    Oosterhuis B; ten Berge IJ; Schellekens PT; van Boxtel CJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):716-22. PubMed ID: 2960797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects.
    Kovarik JM; Hartmann S; Bartlett M; Riviere GJ; Neddermann D; Wang Y; Port A; Schmouder RL
    Biopharm Drug Dispos; 2007 Mar; 28(2):97-104. PubMed ID: 17230596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral dosing paradigms (gavage versus diet) on pharmacokinetics and pharmacodynamics.
    Kapetanovic IM; Krishnaraj R; Martin-Jimenez T; Yuan L; van Breemen RB; Lyubimov A
    Chem Biol Interact; 2006 Dec; 164(1-2):68-75. PubMed ID: 17027946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of prednisolone in asthmatic patients with a poor response to steroid treatment.
    Mortimer O; Grettve L; Lindström B; Lönnerholm G; Zetterström O
    Eur J Respir Dis; 1987 Nov; 71(5):372-9. PubMed ID: 3443161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.